EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection. - Wikidata - wikimedia - TriplyDB

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

http://www.wikidata.org/entity/Q36762987

about

In vivo assessment of behavioral recovery and circulatory exchange in the peritoneal parabiosis model.Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration Effects of preoperative chronic hypoxemia on geriatrics outcomes after hip arthroplasty: A hospital-based retrospective analysis study.Prolyl Hydroxylase Domain-2 Inhibition Improves Skeletal Muscle Regeneration in a Male Murine Model of Obesity Remote ischaemic preconditioning: closer to the mechanism?Metabolic Signature of Remote Ischemic Preconditioning Involving a Cocktail of Amino Acids and Biogenic Amines.Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism Cardioprotection by the transfer of coronary effluent from ischaemic preconditioned rat hearts: identification of cardioprotective humoral factors.AMPK/α-Ketoglutarate Axis Dynamically Mediates DNA Demethylation in the Prdm16 Promoter and Brown Adipogenesis An overview of renal metabolomics.Cardioprotection by remote ischemic conditioning and its signal transduction.Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.EGLN1/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes HIF1α and metabolic reprogramming in inflammation.Kynurenine aminotransferase activity of Aro8/Aro9 engage tryptophan degradation by producing kynurenic acid in Saccharomyces cerevisiae.Potential humoral mediators of remote ischemic preconditioning in patients undergoing surgical coronary revascularization.William Kaelin, Peter Ratcliffe, and Gregg Semenza receive the 2016 Albert Lasker Basic Medical Research Award.Chromatin remodeling factor lymphoid-specific helicase inhibits ferroptosis through lipid metabolic genes in lung cancer progression.Letter in response to remote ischaemic conditioning provides humoral cross-species cardioprotection through glycine receptor activation.Exploring effects of remote ischemic preconditioning in a pig model of hypothermic circulatory arrest.Assessing renal changes after remote ischemic preconditioning (RIPC) of the upper extremity using BOLD imaging at 3T.Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?Targeting Oxygen-Sensing Prolyl Hydroxylase for Metformin-Associated Lactic Acidosis Treatment.Lung protection in patients undergoing pulmonary lobectomy: a new perspective for remote ischemic conditioning in surgery?Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects.Hypoxia-inducible factor cell non-autonomously regulates stress responses and behavior via a nuclear receptor

P2860

Q27333976-6CB2DB7E-F7C5-40C9-8038-86F2D4B03012 Q28078462-7E13CBE1-B7D5-44A7-A740-3DE41C80B2E2 Q33597294-51B976DB-4507-475D-88BF-5F38DC9B6646 Q33871940-0372EEB6-BD1A-4E16-869E-BB2B5BF60A2E Q34680698-9C63A762-D6AF-401D-962B-834F4561637B Q37364477-12C871C2-9E38-4A10-B2C1-1DC5F9B20FD7 Q37737233-98429B20-B442-43F5-927C-7CFB2D7B17E1 Q38684881-FEEF86FC-FB7A-46CD-8D68-73A778E23431 Q38745640-3BD03073-C8B5-4CA7-8F53-042137173ED5 Q38815775-9FA3A411-D9F1-4552-A9B4-85735EA8A118 Q39032510-228092CE-4EB4-4B2C-AB6C-05A73A04BDBA Q39323549-0167BCA8-D076-4BEA-9EF8-539C5A5C12D4 Q41112435-767B7AC7-9EA3-4841-A230-682C471592FD Q41239680-69142F49-46BB-4203-9D68-6A0A3E319FD0 Q41678886-C47FFE06-221B-4BBA-BDA1-33153AACB9FE Q41866532-26CF9D63-19E5-4021-9EBA-C5A6A709729C Q42039904-8093EEBE-BBF2-4B7E-BBB0-ACC265D120A3 Q42373787-35A290EA-E38C-4430-9721-45C85BF12594 Q42690415-F9CBEABC-E8E9-4827-9C37-90B5B70EDFB9 Q46397426-AB064B3B-CDA1-4B67-8C9A-E54EB85CBE75 Q47304323-335F5EDC-CFD0-4EC0-8C26-BA93B351209C Q47880536-C827FC57-58BC-405C-AD07-BCE2D25CEF34 Q47893488-07B97114-7D29-4C3E-97FF-84116EF6681C Q48290609-52B5F583-4583-4BAD-A892-046B98BBA910 Q55176410-4F7E4D31-3026-42AD-AF31-8B0FA3E9E039 Q55383231-322DADBD-1F7E-4096-A163-7A1F2BE70047 Q56535212-B6CB6BD2-9DBE-4462-8E7D-A0E3DD2A95FD

P2860

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

http://www.wikidata.org/entity/Q36762987

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

@ast

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

@en

type

label

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

@ast

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

@en

prefLabel

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

@ast

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

@en

P1433

Q36762987-3AB2C78C-F125-40F3-9C6F-6A3FB847CA33

P1476

Q36762987-5DCD625C-298C-48A7-9228-76D7765EB7F2

P2093

Q36762987-08AD323C-4377-4D22-9D88-956331395F5C

Q36762987-0DBDF3ED-B52B-4CB3-85A4-F8F39ECA6712

Q36762987-31ADE706-5432-4C8C-88E7-AAF1B54432BA

Q36762987-6D70155A-6D36-4AF3-BBCB-AC402F341794

Q36762987-77155BC9-9AE7-4873-807B-0679BDDB1868

Q36762987-7D9A8508-0E74-41B9-9261-2751A7063791

Q36762987-7E2AE9F3-9E51-4330-AB1D-35B661C076CE

Q36762987-80430ACD-A800-476E-BEFF-011846ACDEF3

Q36762987-82DE2193-5E7F-4BCD-9497-D26CE5872DEB

Q36762987-8E7479A7-5F23-4794-864D-D462D35BCD10

P2860

Q36762987-02085AE2-8CEF-4981-94D0-E3ED398B5D19

Q36762987-04F89B3E-9689-49DA-966C-1082381737C5

Q36762987-05871A25-5ED0-4456-946B-2CE2E604FAD2

Q36762987-0643DF5F-E42D-47BF-B851-CA282F3DE765

Q36762987-0790213D-729D-4A12-98D7-17583632BADB

Q36762987-15F8FF58-2F9C-45EC-9D05-64B17A03B636

Q36762987-17826D91-A833-419F-8594-82C7C1F85BAE

Q36762987-21C749AD-B801-432F-9617-086AB00AEF3C

Q36762987-273665B7-4595-42E1-83E6-6F39E6365740

Q36762987-27EE0FCD-CBCC-4DC4-84B1-F7C1D6A0CDFD

P304

Q36762987-8FC551AF-A9BC-41E5-91DB-CB361CCBA139

P31

Q36762987-ED1B0D7E-2078-4F4B-AC62-F6E9A3575ECA

P356

Q36762987-952B6A1E-5579-48DC-B39C-74FA012A4311

P407

Q36762987-C3FAC05B-D0B3-43EA-AC95-4A3D05B13505

P433

Q36762987-C2792189-0869-43B2-AEC8-4F5715B8E7D6

P478

Q36762987-98612D3B-6F5F-4F94-B634-BEE58D7042B4

P50

Q36762987-01367283-2E8D-49E8-ABC7-93174F28F85D

P577

Q36762987-D8F1C0A6-1274-422B-AC49-209646548A1E

P698

Q36762987-AAB9C216-4324-4603-AFB2-C8AB361E4C82

P932

Q36762987-83DFA86B-BA24-4B21-8189-98B4AD654B67

P356

J.CELL.2016.02.006

P1433

P1476

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

@en

P2093

Abhishek A Chakraborty

http://www.w3.org/2001/XMLSchema#string

Alan H Baik

http://www.w3.org/2001/XMLSchema#string

Ameeta Kelekar

http://www.w3.org/2001/XMLSchema#string

Amy J Wagers

http://www.w3.org/2001/XMLSchema#string

Benjamin A Olenchock

http://www.w3.org/2001/XMLSchema#string

Christine M Miller

http://www.w3.org/2001/XMLSchema#string

Clary B Clish

http://www.w3.org/2001/XMLSchema#string

Eric A Hanse

http://www.w3.org/2001/XMLSchema#string

Javid Moslehi

http://www.w3.org/2001/XMLSchema#string

Jeremy Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival

Hypoxia-inducible factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodelling

Relating tissue/organ energy expenditure to metabolic fluxes in mouse and human: experimental data integrated with mathematical modeling

Metabolite profiles and the risk of developing diabetes

Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

Conditional HIF-1alpha expression produces a reversible cardiomyopathy.

P304

884-895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2016.02.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

William G. Kaelin

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26919427

http://www.w3.org/2001/XMLSchema#string

P932

4819986

http://www.w3.org/2001/XMLSchema#string